Clinical Trial Update: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Maridebart Cafraglutide in adults with Type 2 Diabetes Mellitus who are obese or overweight; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Phase 3 | Status: ACTIVE_NOT_RECRUITING